BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

139 related articles for article (PubMed ID: 34318428)

  • 21. MicroRNA-126 Inhibits Proliferation, Migration, Invasion, and EMT in Osteosarcoma by Targeting ZEB1.
    Jiang R; Zhang C; Liu G; Gu R; Wu H
    J Cell Biochem; 2017 Nov; 118(11):3765-3774. PubMed ID: 28379605
    [TBL] [Abstract][Full Text] [Related]  

  • 22. MicroRNA-1296 inhibits metastasis and epithelial-mesenchymal transition of hepatocellular carcinoma by targeting SRPK1-mediated PI3K/AKT pathway.
    Xu Q; Liu X; Liu Z; Zhou Z; Wang Y; Tu J; Li L; Bao H; Yang L; Tu K
    Mol Cancer; 2017 Jun; 16(1):103. PubMed ID: 28606154
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [microRNA-16-5p targeted tetraspanin 15 gene to inhibit the proliferation, migration and invasion of osteosarcoma cell through phospoinositide 3-kinase/protein kinase B signaling pathway].
    Yu JB; Zhang HJ; Yan LW; Chang F; Jia ZW; Yang XR
    Zhonghua Yi Xue Za Zhi; 2020 Jun; 100(21):1668-1675. PubMed ID: 32486604
    [No Abstract]   [Full Text] [Related]  

  • 24. MicroRNA-493-5p inhibits proliferation and metastasis of osteosarcoma cells by targeting Kruppel-like factor 5.
    Zhang Z; Luo G; Yu C; Yu G; Jiang R; Shi X
    J Cell Physiol; 2019 Aug; 234(8):13525-13533. PubMed ID: 30773645
    [TBL] [Abstract][Full Text] [Related]  

  • 25. microRNA-377-3p inhibits osteosarcoma progression by targeting CUL1 and regulating Wnt/β-catenin signaling pathway.
    Liang K; Liao L; Liu Q; Ouyang Q; Jia L; Wu G
    Clin Transl Oncol; 2021 Nov; 23(11):2350-2357. PubMed ID: 34133001
    [TBL] [Abstract][Full Text] [Related]  

  • 26. MiR-1224-5p Activates Autophagy, Cell Invasion and Inhibits Epithelial-to-Mesenchymal Transition in Osteosarcoma Cells by Directly Targeting PLK1 Through PI3K/AKT/mTOR Signaling Pathway.
    Jin B; Jin D; Zhuo Z; Zhang B; Chen K
    Onco Targets Ther; 2020; 13():11807-11818. PubMed ID: 33235467
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Down-regulation of MIAT suppresses osteosarcoma progression by acting as a ceRNA for miR-141-3p to regulate SIX1-mediated PI3K/AKT pathway.
    Ji Q; Zhu J; Fang CL; Jin H; Zhan DP; Huang J
    Eur Rev Med Pharmacol Sci; 2020 Mar; 24(5):2218-2228. PubMed ID: 32196573
    [TBL] [Abstract][Full Text] [Related]  

  • 28. The expression and function of miRNA-106 in pediatric osteosarcoma.
    Xu M; Zhang YY; Wang HF; Yang GS
    Eur Rev Med Pharmacol Sci; 2017 Feb; 21(4):715-722. PubMed ID: 28272712
    [TBL] [Abstract][Full Text] [Related]  

  • 29. miR-138 Reduces the Dysfunction of T Follicular Helper Cells in Osteosarcoma via the PI3K/Akt/mTOR Pathway by Targeting PDK1.
    Jiang B; Kang X; Zhao G; Lu J; Wang Z
    Comput Math Methods Med; 2021; 2021():2895893. PubMed ID: 34950224
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Knocking down miR-384 promotes growth and metastasis of osteosarcoma MG63 cells by targeting SLBP.
    Wang Y; Huang H; Li Y
    Artif Cells Nanomed Biotechnol; 2019 Dec; 47(1):1458-1465. PubMed ID: 31007083
    [TBL] [Abstract][Full Text] [Related]  

  • 31. MicroRNA-92a promotes epithelial-mesenchymal transition through activation of PTEN/PI3K/AKT signaling pathway in non-small cell lung cancer metastasis.
    Lu C; Shan Z; Hong J; Yang L
    Int J Oncol; 2017 Jul; 51(1):235-244. PubMed ID: 28534966
    [TBL] [Abstract][Full Text] [Related]  

  • 32. AIM2 inhibits the proliferation, invasion and migration, and promotes the apoptosis of osteosarcoma cells by inactivating the PI3K/AKT/mTOR signaling pathway.
    Zheng J; Liu C; Shi J; Wen K; Wang X
    Mol Med Rep; 2022 Feb; 25(2):. PubMed ID: 34913077
    [TBL] [Abstract][Full Text] [Related]  

  • 33. MiR-501-3p promotes osteosarcoma cell proliferation, migration and invasion by targeting BCL7A.
    Dai J; Lu L; Kang L; Zhang J
    Hum Cell; 2021 Mar; 34(2):624-633. PubMed ID: 33415690
    [TBL] [Abstract][Full Text] [Related]  

  • 34. miR-300 regulates the epithelial-mesenchymal transition and invasion of hepatocellular carcinoma by targeting the FAK/PI3K/AKT signaling pathway.
    Wang R; Yu Z; Chen F; Xu H; Shen S; Chen W; Chen L; Su Q; Zhang L; Bi J; Zeng W; Li W; Huang X; Wang Q
    Biomed Pharmacother; 2018 Jul; 103():1632-1642. PubMed ID: 29864952
    [TBL] [Abstract][Full Text] [Related]  

  • 35. miR-92a promotes tumor growth of osteosarcoma by targeting PTEN/AKT signaling pathway.
    Xiao J; Yu W; Hu K; Li M; Chen J; Li Z
    Oncol Rep; 2017 Apr; 37(4):2513-2521. PubMed ID: 28260104
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Targeting of SPP1 by microRNA-340 inhibits gastric cancer cell epithelial-mesenchymal transition through inhibition of the PI3K/AKT signaling pathway.
    Song SZ; Lin S; Liu JN; Zhang MB; Du YT; Zhang DD; Xu WH; Wang HB
    J Cell Physiol; 2019 Aug; 234(10):18587-18601. PubMed ID: 30953349
    [TBL] [Abstract][Full Text] [Related]  

  • 37. miR-624-5p promoted tumorigenesis and metastasis by suppressing hippo signaling through targeting PTPRB in osteosarcoma cells.
    Luo Y; Liu W; Tang P; Jiang D; Gu C; Huang Y; Gong F; Rong Y; Qian D; Chen J; Zhou Z; Zhao S; Wang J; Xu T; Wei Y; Yin G; Fan J; Cai W
    J Exp Clin Cancer Res; 2019 Dec; 38(1):488. PubMed ID: 31829261
    [TBL] [Abstract][Full Text] [Related]  

  • 38. MicroRNA-1253 Suppresses Cell Proliferation Migration and Invasion of Osteosarcoma by Targeting MMP9.
    Mo J; Zheng T; Lei L; Dai P; Liu J; He H; Shi J; Chen X; Guo T; Yuan B; Ji G
    Technol Cancer Res Treat; 2021; 20():1533033821995278. PubMed ID: 34036868
    [TBL] [Abstract][Full Text] [Related]  

  • 39. MiR-592 Promotes Gastric Cancer Proliferation, Migration, and Invasion Through the PI3K/AKT and MAPK/ERK Signaling Pathways by Targeting Spry2.
    He Y; Ge Y; Jiang M; Zhou J; Luo D; Fan H; Shi L; Lin L; Yang L
    Cell Physiol Biochem; 2018; 47(4):1465-1481. PubMed ID: 29949784
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Effects of miR-202-5p silencing PIK3CA gene expression on proliferation, invasion, and epithelial-mesenchymal transition of cervical cancer SiHa cells through inhibiting PI3K/Akt/mTOR signaling pathway activation.
    Zheng Y; Xie L; Xu S; Yan W; Zhang H; Meng Y; Liu J; Wei X
    Mol Cell Biochem; 2021 Nov; 476(11):4031-4044. PubMed ID: 34244973
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.